PT Central Proteinaprima Tbk (ISX:CPRO) EBIT: Rp695,520 Mil (TTM As of Mar. 2026)


ISX:CPRO PT Central Proteinaprima Tbk ISX:CPRO
71 GF Score
Price Rp50.00
GF Value Rp57.49
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is PT Central Proteinaprima Tbk EBIT?

PT Central Proteinaprima Tbk ISX:CPRO 71 EBIT is Rp695,520 Mil as of Mar. 2026. GuruFocus rates ISX:CPRO with a GF Score™ of 71/100 and a GF Value™ of Rp57.49 (Modestly Undervalued). The stock has 2 warning signs investors should review.

PT Central Proteinaprima Tbk's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was Rp163,373 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was Rp695,520 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. PT Central Proteinaprima Tbk's annualized ROC % for the quarter that ended in Mar. 2026 was 8.23%. PT Central Proteinaprima Tbk's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 12.22%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. PT Central Proteinaprima Tbk's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 14.95%.


PT Central Proteinaprima Tbk  (ISX:CPRO) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

PT Central Proteinaprima Tbk's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=698888 * ( 1 - 26.06% )/( (6190594 + 6360424)/ 2 )
=516757.7872/6275509
=8.23 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=7217396 - 891321 - ( 135481 - max(0, 2828200 - 3091050+135481))
=6190594

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=7085618 - 620354 - ( 104840 - max(0, 2597854 - 2932780+104840))
=6360424

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

PT Central Proteinaprima Tbk's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=653492/( ( (3517364 + max(1724633, 0)) + (3534543 + max(1918411, 0)) )/ 2 )
=653492/( ( 5241997 + 5452954 )/ 2 )
=653492/5347475.5
=12.22 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(992464 + 1885826 + 71443) - (891321 + 0 + 333779)
=1724633

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(993905 + 1705491 + 121573) - (620354 + 0 + 282204)
=1918411

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

PT Central Proteinaprima Tbk's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=695520/4651668.139
=14.95 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Central Proteinaprima Tbk EBIT Related Terms


PT Central Proteinaprima Tbk EBIT Historical Data

* Premium members only.

The historical data trend for PT Central Proteinaprima Tbk's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Central Proteinaprima Tbk EBIT Chart

PT Central Proteinaprima Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,510,253.00 695,128.00 720,640.00 632,535.00 776,808.00

PT Central Proteinaprima Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 244,661.00 212,297.00 218,737.00 101,113.00 163,373.00

ISX:CPRO vs ADM, BG, TSN: EBIT Comparison

For the Farm Products subindustry, PT Central Proteinaprima Tbk's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Central Proteinaprima Tbk EV-to-EBIT vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, PT Central Proteinaprima Tbk's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where PT Central Proteinaprima Tbk's EV-to-EBIT falls into.


ISX:CPRO
71GF Score
PT Central Proteinaprima Tbk ISX:CPRO
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Central Proteinaprima Tbk EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp695,520 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of Rp695,520 Mil mean?
PT Central Proteinaprima Tbk (ISX:CPRO) has a EBIT of Rp695,520 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on PT Central Proteinaprima Tbk.
Is PT Central Proteinaprima Tbk's EBIT too high?
PT Central Proteinaprima Tbk's current EBIT is Rp695,520 Mil. Overall, PT Central Proteinaprima Tbk has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Central Proteinaprima Tbk's EBIT compare to ADM and BG?
PT Central Proteinaprima Tbk's EBIT of Rp695,520 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Consumer Packaged Goods company?
A good EBIT depends on the Consumer Packaged Goods industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on PT Central Proteinaprima Tbk. PT Central Proteinaprima Tbk's current EBIT is Rp695,520 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Central Proteinaprima Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Central Proteinaprima Tbk (ISX:CPRO) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp57.49, compared to a current price of Rp50.00 — trading 13% below its estimated fair value. The current EBIT is Rp695,520 Mil. PT Central Proteinaprima Tbk's overall GF Score™ is 71/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For PT Central Proteinaprima Tbk (ISX:CPRO), the current EBIT is Rp695,520 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Central Proteinaprima Tbk (ISX:CPRO) Overvalued in 2026?

Based on GuruFocus' analysis, PT Central Proteinaprima Tbk stock appears to be undervalued. The current stock price of Rp50.00 is trading 13% below its estimated GF Value™ of Rp57.49. GuruFocus considers PT Central Proteinaprima Tbk to be Modestly Undervalued.

Key valuation signals for ISX:CPRO:

  • EBIT: Rp695,520 Mil
  • GF Value™: Rp57.49 vs. price of Rp50.00 (13% below fair value)
  • GF Score™: 71/100 with 2 warning signs

No single metric tells the full story. See the ISX:CPRO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Central Proteinaprima Tbk Business Description

Address Jalan Jendral sudirman Kavling 52-53, Treasury Tower, 8th Floor, District 8 SCBD Lot. 28, Jakarta, IDN, 12190
PT Central Proteinaprima Tbk is an Indonesia-based aquaculture company. Principally, it is engaged in integrated shrimp farming, production, and sale of shrimp, fish, and other livestock feeds. It operates in three segments: Feeds, Food products, and others, of which the majority of the revenue comes from the feeds segment. Also, it provides hatchery services. It offers animal feed products such as Irawan, Bintang, Indo Feed, Pakan Udang Galah, Pakan Udang Bestariand, and Pakan Udang Marine. The majority of the revenue is generated from the domestic market.
71GF Score

Get the complete analysis for ISX:CPRO

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp50.00
Price
Rp57.49
GF Value